跳至主要内容
临床试验/NCT05376046
NCT05376046招募中不适用

Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease

BILLOIR1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2018年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
Hospitalisation for Vaso-occlusive crisis within one years

研究概览

简要总结

Sickle cell disease (SCD) is an inherited haemoglobinopathy disorder caused by mutations in HBB gene with amino-acid substitution on β globin chain. The consequence is synthesis of altered haemoglobin S (HbS) which polymerises in red blood cell (RBC) at deoxygenated state. SCD is associated with chronic haemolytic anaemia, vaso-occlusive crisis (VOC) leading to frequent hospitalisation.

The aim of the study was to to investigate whether a combination of routine laboratory biomarkers of haemolysis could be used to predict VOC development in confirmed SCD patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Sickle cell disease

排除标准

  • <18 years
  • pregnancy
  • Patient under protective guardianship or curatorship

结局指标

主要结局

Hospitalisation for Vaso-occlusive crisis within one years

时间窗: 1 year

Following injury consultation, evaluation of biological markers predicting vaso-occlusive crisis requiring hospitalisation in the year

次要结局

未报告次要终点

研究者

发起方
BILLOIR
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

BILLOIR

Associate Professor

University Hospital, Rouen

研究点 (1)

Loading locations...

相似试验

Study of Erythrocyte Parameters and... | 临床试验